ACAAI Review for the Allergy and Immunology Boards - American ...

More documents

Recommendations

Info

DEDICATIONTo our families, friends, and loved ones, who encouraged and assisted us in the task ofassembling this guide.
Page 1 and 2: ACAUNOLOGY ACAAI REVIEWFORALLERGYTH
Page 3: American College of Allergy, Asthma
Page 7: Chapter 4. Laboratory Tests 111Soni
Page 10 and 11: CONTRIBUTING AUTHORSSonia N. Bains,
Page 12 and 13: SENIOR REVIEWERSAmal Assa’ad, MDP
Page 14 and 15: PREFACEWith this first edition of A
Page 16 and 17: ACKNOWLEDGMENTSThis has been a coll
Page 18 and 19: HOW TO CONTRIBUTETo continue to pro
Page 20 and 21: xix
Page 22 and 23: 2 / CHAPTER 1Table 1-1. Superantige
Page 24 and 25: 4 / CHAPTER 1Table 1-2. Factors Inf
Page 26 and 27: 6 / CHAPTER 1Table 1-4. Cells That
Page 28 and 29: 8 / CHAPTER 1Figure 1-4. MHC class
Page 30 and 31: 10 / CHAPTER 1IMMUNOLOGIC TOLERANCE
Page 32 and 33: 12 / CHAPTER 1Key FactLack of costi
Page 34 and 35: 14 / CHAPTER 1Table 1-7. Summary of
Page 36 and 37: 16 / CHAPTER 1Table 1-8. Types of M
Page 38 and 39: 18 / CHAPTER 1Key FactOmalizumab bi
Page 40 and 41: 20 / CHAPTER 1Only IgG crosses plac
Page 42 and 43: 22 / CHAPTER 1General Functions of
Page 44 and 45: 24 / CHAPTER 1T CELL RECEPTORS AND
Page 46 and 47: 26 / CHAPTER 1Table 1-14. Costimula
Page 48 and 49: 28 / CHAPTER 1Figure 1-7. TCR compl
Page 50 and 51: 30 / CHAPTER 1Rac-GTP is another mo
Page 52 and 53: 32 / CHAPTER 1B Lymphocyte Signalin
Page 54 and 55:
34 / CHAPTER 1Table 1-16. Gene Defe
Page 56 and 57:
36 / CHAPTER 1Table 1-17. Cytokines
Page 58 and 59:
38 / CHAPTER 1Cytokines That Mediat
Page 60 and 61:
40 / CHAPTER 1Table 1-18. Cytokines
Page 62 and 63:
42 / CHAPTER 1CHEMOKINESChemokines
Page 64 and 65:
44 / CHAPTER 1Table 1-22. Summary o
Page 66 and 67:
46 / CHAPTER 1Pathways of Complemen
Page 68 and 69:
48 / CHAPTER 1Figure 1-12. Lectin p
Page 70 and 71:
50 / CHAPTER 1Membranoproliferative
Page 72 and 73:
52 / CHAPTER 1Figure 1-13. Contact
Page 74 and 75:
54 / CHAPTER 1PathophysiologyWhen f
Page 76 and 77:
56 / CHAPTER 1Oral ToleranceIn both
Page 78 and 79:
58 / CHAPTER 1FIGURE 1-15. Gastroin
Page 80 and 81:
60 / CHAPTER 1Measure response of i
Page 82 and 83:
62 / CHAPTER 1Primed helper T lymph
Page 84 and 85:
64 / CHAPTER 1Human tumors produce
Page 86 and 87:
66 / CHAPTER 1Key FactAMPs are decr
Page 88 and 89:
68 / CHAPTER 1TOLL-LIKE RECEPTORSTo
Page 90 and 91:
Cell Number70 / CHAPTER 1TLR agonis
Page 92 and 93:
72 / CHAPTER 2Natural Killer T (NKT
Page 94 and 95:
74 / CHAPTER 2Table 2-5. B Cell Mat
Page 96 and 97:
76 / CHAPTER 2Expression of a molec
Page 98 and 99:
78 / CHAPTER 2Macrophage Morphology
Page 100 and 101:
80 / CHAPTER 2Figure 2-4. Dendritic
Page 102 and 103:
82 / CHAPTER 2The α chain contains
Page 104 and 105:
84 / CHAPTER 2BASOPHILSBasophils ar
Page 106 and 107:
86 / CHAPTER 2EOSINOPHILSEosinophil
Page 108 and 109:
88 / CHAPTER 2NEUTROPHILSNeutrophil
Page 110 and 111:
90 / CHAPTER 2Table 2-13. Congenita
Page 112 and 113:
92 / CHAPTER 2Figure 2-11. Thrombus
Page 114 and 115:
94 / CHAPTER 2Figure 2-12. Types of
Page 116 and 117:
96 / CHAPTER 2Endothelial Cells in
Page 118 and 119:
98 / CHAPTER 3PathophysiologyThere
Page 120 and 121:
100 / CHAPTER 3Intravenous fluids (
Page 122 and 123:
102 / CHAPTER 3Complement FixationO
Page 124 and 125:
104 / CHAPTER 3IMMUNE COMPLEX-MEDIA
Page 126 and 127:
106 / CHAPTER 3Serum Sickness—Imm
Page 128 and 129:
108 / CHAPTER 3CD8+ T cells contain
Page 130 and 131:
110 / CHAPTER 3Key FactDefect in NK
Page 132 and 133:
112 / CHAPTER 4Table 4-1. Immunoass
Page 134 and 135:
114 / CHAPTER 4Figure 4-4. Laurell
Page 136 and 137:
116 / CHAPTER 4Figure 4-7. 96-well
Page 138 and 139:
118 / CHAPTER 4Western Blot (Protei
Page 140 and 141:
120 / CHAPTER 4Figure 4-12. IgG ver
Page 142 and 143:
122 / CHAPTER 4Figure 4-14. ImmunoC
Page 144 and 145:
124 / CHAPTER 4Interleukins and TNF
Page 146 and 147:
126 / CHAPTER 4Table 4-4. Cell Surf
Page 148 and 149:
128 / CHAPTER 4Table 4-4. Cell Surf
Page 150 and 151:
130 / CHAPTER 4Table 4-6. CD28 Fami
Page 152 and 153:
132 / CHAPTER 4Table 4-10. Compleme
Page 154 and 155:
134 / CHAPTER 4Table 4-12. Lymphocy
Page 156 and 157:
136 / CHAPTER 4LYMPHOCYTE FUNCTION:
Page 158 and 159:
Cell Number138 / CHAPTER 4NormalAbn
Page 160 and 161:
CD14 (Monocytes) CD19 (B Cells)140
Page 162 and 163:
142 / CHAPTER 4Key FactPokeweed mit
Page 164 and 165:
144 / CHAPTER 4Chédiak-Higashi syn
Page 166 and 167:
146 / CHAPTER 4Figure 4-22. Respira
Page 168 and 169:
148 / CHAPTER 4HYBRIDOMA AND MONOCL
Page 170 and 171:
150 / CHAPTER 4-umab Human Human he
Page 172 and 173:
152 / CHAPTER 4Table 4-20. Examples
Page 174 and 175:
154 / CHAPTER 4occurred, because th
Page 176 and 177:
156 / CHAPTER 4Advantages—Most se
Page 178 and 179:
158 / CHAPTER 4Uses—To genotype o
Page 180 and 181:
160 / CHAPTER 5ThymusOnce generated
Page 182 and 183:
162 / CHAPTER 5SECONDARY (PERIPHERA
Page 184 and 185:
164 / CHAPTER 5SpleenThe spleen is
Page 186 and 187:
166 / CHAPTER 5ABFigure 5-4. Nasal
Page 188 and 189:
168 / CHAPTER 5Nasal Fluid and Muco
Page 190 and 191:
170 / CHAPTER 5Increasing resonance
Page 192 and 193:
172 / CHAPTER 5Figure 5-7. Sputum f
Page 194 and 195:
174 / CHAPTER 5EpidermisPrincipal c
Page 196 and 197:
176 / CHAPTER 5Table 5-3. Immunobul
Page 198 and 199:
178 / CHAPTER 5Antimicrobial Peptid
Page 200 and 201:
180 / CHAPTER 5Celiac DiseaseCeliac
Page 202 and 203:
182 / CHAPTER 6Figure 6-1. Uniform
Page 204 and 205:
184 / CHAPTER 6Table 6-2. Parametri
Page 206 and 207:
186 / CHAPTER 6Example: A new aller
Page 208 and 209:
188 / CHAPTER 6Internal validity is
Page 210 and 211:
190 / CHAPTER 6Elements of informed
Page 212 and 213:
192 / CHAPTER 7Decreased exposure t
Page 214 and 215:
194 / CHAPTER 7as defined by Allerg
Page 216 and 217:
196 / CHAPTER 7ASA and NSAIDs (as a
Page 218 and 219:
198 / CHAPTER 7Signs and SymptomsTh
Page 220 and 221:
200 / CHAPTER 7TreatmentTreatment f
Page 222 and 223:
202 / CHAPTER 7Three years of age o
Page 224 and 225:
204 / CHAPTER 7Figure 7-1. Tympanog
Page 226 and 227:
206 / CHAPTER 7CONJUNCTIVITISALLERG
Page 228 and 229:
208 / CHAPTER 7PathologySimilarly t
Page 230 and 231:
210 / CHAPTER 7Figure 7-5. Contact
Page 232 and 233:
212 / CHAPTER 7Key FactIn an adult
Page 234 and 235:
214 / CHAPTER 7CheilitisNipple ecze
Page 236 and 237:
216 / CHAPTER 7The differential dia
Page 238 and 239:
218 / CHAPTER 7Cytokine secretion (
Page 240 and 241:
220 / CHAPTER 7Table 7-5. Different
Page 242 and 243:
222 / CHAPTER 7ExerciseExercise is
Page 244 and 245:
224 / CHAPTER 7Table 7-10. Assessin
Page 246 and 247:
226 / CHAPTER 7Table 7-12. Assessin
Page 248 and 249:
228 / CHAPTER 7Fumes: aluminum oxid
Page 250 and 251:
230 / CHAPTER 7Lung DiseasesReactiv
Page 252 and 253:
232 / CHAPTER 7DiagnosisTable 7-15
Page 254 and 255:
234 / CHAPTER 7Figure 7-6. Pathophy
Page 256 and 257:
236 / CHAPTER 7HYPERSENSITIVITY PNE
Page 258 and 259:
238 / CHAPTER 7The following presen
Page 260 and 261:
240 / CHAPTER 7Usual Interstitial P
Page 263 and 264:
HYPERSENSITIVITY DISORDERS / 243Fre
Page 265 and 266:
HYPERSENSITIVITY DISORDERS / 245Pat
Page 267 and 268:
HYPERSENSITIVITY DISORDERS / 247Tab
Page 269 and 270:
HYPERSENSITIVITY DISORDERS / 249Pea
Page 271 and 272:
HYPERSENSITIVITY DISORDERS / 251Dia
Page 273 and 274:
HYPERSENSITIVITY DISORDERS / 253Key
Page 275 and 276:
Page 277 and 278:
HYPERSENSITIVITY DISORDERS / 257A B
Page 279 and 280:
Page 281 and 282:
Page 283 and 284:
HYPERSENSITIVITY DISORDERS / 263Com
Page 285 and 286:
HYPERSENSITIVITY DISORDERS / 265all
Page 287 and 288:
HYPERSENSITIVITY DISORDERS / 267Der
Page 289 and 290:
Page 291 and 292:
HYPERSENSITIVITY DISORDERS / 271Acu
Page 293 and 294:
HYPERSENSITIVITY DISORDERS / 273Aqu
Page 295 and 296:
HYPERSENSITIVITY DISORDERS / 275“
Page 297 and 298:
HYPERSENSITIVITY DISORDERS / 277The
Page 299 and 300:
HYPERSENSITIVITY DISORDERS / 279The
Page 301 and 302:
HYPERSENSITIVITY DISORDERS / 281Mne
Page 303 and 304:
HYPERSENSITIVITY DISORDERS / 283Uni
Page 305 and 306:
HYPERSENSITIVITY DISORDERS / 285Tre
Page 307 and 308:
HYPERSENSITIVITY DISORDERS / 287Sup
Page 309 and 310:
8Immunologic DisordersHEREDITARY AN
Page 311 and 312:
IMMUNOLOGIC DISORDERS / 291against
Page 313 and 314:
IMMUNOLOGIC DISORDERS / 293Second-T
Page 315 and 316:
CD4 & CD8CD19IMMUNOLOGIC DISORDERS
Page 317 and 318:
IMMUNOLOGIC DISORDERS / 297Table 8-
Page 319 and 320:
Page 321 and 322:
Page 323 and 324:
CD14 (Monocytes) CD19 (B Cells)IMMU
Page 325 and 326:
Page 327 and 328:
Cell NumberIMMUNOLOGIC DISORDERS /
Page 329 and 330:
IMMUNOLOGIC DISORDERS / 309Mycobact
Page 331 and 332:
Page 333 and 334:
IMMUNOLOGIC DISORDERS / 313repeated
Page 335 and 336:
IMMUNOLOGIC DISORDERS / 315Diagnosi
Page 337 and 338:
IMMUNOLOGIC DISORDERS / 317Key Fact
Page 339 and 340:
IMMUNOLOGIC DISORDERS / 319General
Page 341 and 342:
IMMUNOLOGIC DISORDERS / 321Treatmen
Page 343 and 344:
IMMUNOLOGIC DISORDERS / 323Anti-Ro:
Page 345 and 346:
Page 347 and 348:
IMMUNOLOGIC DISORDERS / 327similar
Page 349 and 350:
IMMUNOLOGIC DISORDERS / 329Allogene
Page 351 and 352:
IMMUNOLOGIC DISORDERS / 331used in
Page 353 and 354:
IMMUNOLOGIC DISORDERS / 333Mnemonic
Page 355 and 356:
Page 357 and 358:
Page 359 and 360:
IMMUNOLOGIC DISORDERS / 339autoimmu
Page 361 and 362:
Page 363 and 364:
IMMUNOLOGIC DISORDERS / 343Both hum
Page 365 and 366:
IMMUNOLOGIC DISORDERS / 345Henoch S
Page 367 and 368:
IMMUNOLOGIC DISORDERS / 347Diagnosi
Page 369 and 370:
IMMUNOLOGIC DISORDERS / 349Target P
Page 371 and 372:
IMMUNOLOGIC DISORDERS / 351LUPUS ER
Page 373 and 374:
Page 375 and 376:
IMMUNOLOGIC DISORDERS / 355Celiac D
Page 377 and 378:
IMMUNOLOGIC DISORDERS / 357Symptoms
Page 379 and 380:
Page 381 and 382:
IMMUNOLOGIC DISORDERS / 361Inflamma
Page 383 and 384:
Page 385 and 386:
IMMUNOLOGIC DISORDERS / 365Hypereos
Page 387 and 388:
IMMUNOLOGIC DISORDERS / 367For myel
Page 389 and 390:
Page 391 and 392:
IMMUNOLOGIC DISORDERS / 371Multiple
Page 393 and 394:
IMMUNOLOGIC DISORDERS / 373amino ac
Page 395 and 396:
IMMUNOLOGIC DISORDERS / 375GRANULOM
Page 397 and 398:
Page 399 and 400:
IMMUNOLOGIC DISORDERS / 379MASTOCYT
Page 401 and 402:
Page 403 and 404:
IMMUNOLOGIC DISORDERS / 383acute HT
Page 405 and 406:
IMMUNOLOGIC DISORDERS / 385otherwis
Page 407 and 408:
IMMUNOLOGIC DISORDERS / 387New CXR
Page 409 and 410:
Page 411 and 412:
Page 413 and 414:
IMMUNOLOGIC DISORDERS / 393IgM Capt
Page 415 and 416:
IMMUNOLOGIC DISORDERS / 395Genetics
Page 417 and 418:
IMMUNOLOGIC DISORDERS / 397to HBeAb
Page 419 and 420:
IMMUNOLOGIC DISORDERS / 399Serologi
Page 421 and 422:
9Pharmacology and TherapeuticsALLER
Page 423 and 424:
PHARMACOLOGY AND THERAPEUTICS / 403
Page 425 and 426:
Page 427 and 428:
Page 429 and 430:
Page 431 and 432:
Page 433 and 434:
Page 435 and 436:
Page 437 and 438:
Page 439 and 440:
Page 441 and 442:
Page 443 and 444:
Page 445 and 446:
Page 447 and 448:
Page 449 and 450:
Page 451 and 452:
Page 453 and 454:
Page 455 and 456:
Page 457 and 458:
Page 459 and 460:
Page 461 and 462:
Page 463 and 464:
Page 465 and 466:
Page 467 and 468:
Page 469 and 470:
Page 471 and 472:
Page 473 and 474:
Page 475 and 476:
Page 477 and 478:
Page 479 and 480:
Page 481 and 482:
Page 483 and 484:
10Specific Diagnostic ModalitiesSKI
Page 485 and 486:
SPECIFIC DIAGNOSTIC MODALITIES / 46
Page 487 and 488:
Page 489 and 490:
Page 491 and 492:
Page 493 and 494:
Page 495 and 496:
Page 497 and 498:
Page 499 and 500:
Page 501 and 502:
Page 503 and 504:
Page 505 and 506:
Page 507 and 508:
Page 509 and 510:
Page 511 and 512:
Page 513 and 514:
Page 515 and 516:
Page 517 and 518:
Page 519 and 520:
Page 521 and 522:
Page 523 and 524:
Page 525 and 526:
Page 527 and 528:
Page 529 and 530:
11Allergens and AntigensPOLLENSGRAS
Page 531 and 532:
ALLERGENS AND ANTIGENS / 511WEED PO
Page 533 and 534:
ALLERGENS AND ANTIGENS / 513Figure
Page 535 and 536:
Page 537 and 538:
Page 539 and 540:
Page 541 and 542:
ALLERGENS AND ANTIGENS / 521ABFigur
Page 543 and 544:
ALLERGENS AND ANTIGENS / 523Cladosp
Page 545 and 546:
Page 547 and 548:
ALLERGENS AND ANTIGENS / 527Aureoba
Page 549 and 550:
ALLERGENS AND ANTIGENS / 529o Also
Page 551 and 552:
ALLERGENS AND ANTIGENS / 531and are
Page 553 and 554:
ALLERGENS AND ANTIGENS / 533Indoor
Page 555 and 556:
ALLERGENS AND ANTIGENS / 535Lyophil
Page 557 and 558:
ALLERGENS AND ANTIGENS / 537Pollina
Page 559 and 560:
ALLERGENS AND ANTIGENS / 539Other S
Page 561 and 562:
ALLERGENS AND ANTIGENS / 541Table 1
Page 563 and 564:
Page 565 and 566:
Page 567 and 568:
ALLERGENS AND ANTIGENS / 547Egg all
Page 569 and 570:
ALLERGENS AND ANTIGENS / 549Homolog
Page 571 and 572:
Page 573 and 574:
ABOUT THE EDITORSTao Le, MD, MHSTao
show all

ACAAI Review for the Allergy and Immunology Boards - American ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?